Citation: Sg. Kozlov et al., Assessment of efficacy of fluvastatin and fenofibrate in patients with noninsulin-dependent diabetes with hypercholesterolemia and combined hyperlipidemia, KARDIOLOGIY, 40(5), 2000, pp. 4-9
Authors:
Solovyeva, EY
Rozhkova, TA
Tvorogova, MG
Kukharchuk, VV
Citation: Ey. Solovyeva et al., Cerivastatin - A new synthetic 3-hydroxy-3-methylglutaryl (HMG) inhibitor:Effect of 0.2 mg dose in patients with primary hyperlipidemias, TERAPEVT AR, 71(8), 1999, pp. 30-34
Authors:
Tvorogova, MG
Susekov, AV
Semenova, OA
Kukharchuk, VV
Titov, VN
Citation: Mg. Tvorogova et al., Factors of renal disease progress and probability of regulating these factors in principle, TERAPEVT AR, 70(12), 1998, pp. 5-8
Authors:
Tvorogova, MG
Susekov, AV
Semenova, OA
Kukharchuk, VV
Titov, VN
Citation: Mg. Tvorogova et al., Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia, TERAPEVT AR, 70(12), 1998, pp. 8-13
Authors:
Korotaeva, AA
Golovanova, NK
Vlasik, TN
Yanushevskaya, EV
Tsibulsky, VP
Yakushkin, VV
Tvorogova, MG
Morozkin, AD
Prokazova, NV
Citation: Aa. Korotaeva et al., Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A(2)-treated low density lipoproteins, BIOCHEM-MOS, 63(12), 1998, pp. 1430-1437